Swiss biotech Bioversys AG shares started trading at 36.5 Swiss francs ($40.29) on the SIX Swiss Exchange on Friday, slightly up from the final price for its initial public offering (IPO) of 36 Swiss ...

Switzerland’s top criminal court convicted a multinational company for the first time, ruling against commodities trader ...

By Ariane Luthi ZURICH (Reuters) -Swiss bank Julius Baer plans to cut its workforce by about 5% under new chief executive ...

KfW became the 14th SSA issuer to visit the Swiss franc bond market this year on Thursday, ending a 15-year absence from the ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

In the final month of 2024, exports of watches between 200 and 500 Swiss francs were the hardest hit, with a drop of 13.2 ...

The Swiss franc was flat, but its safe-haven credentials suggest further strength, and if the eurozone comes under pressure from internal politics or a trade war with the U.S. EUR/CHF could fall to 0.

GENEVA - Switzerland's President and Finance Minister Karin Keller-Sutter forecast higher annual budget deficits of around 3 ...

NEW YORK >> The yen and the Swiss franc gained against major currencies today amid a selloff in technology stocks as markets ...

The Mexican peso, a barometer of tariff worries, weakened 1.6% to 20.609 per dollar. The Canadian dollar was down 0.33% ...

By Stefano Rebaudo (Reuters) -The yen and Swiss franc jumped against major currencies on Monday in a rush for safe-haven ...

Swiss banking giant UBS on Tuesday posted $770 million in fourth-quarter net profit, launching a $1 billion share buyback ...